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Abstract
acacia farnesiana is the main source of allergenic pollen and one of the most important causes  
of respiratory allergic disease in tropical and subtropical regions of the world. the purpose of this study 
was to produce a recombinant variety of allergenic ole e 1-like protein from the pollen of this tree. to 
predict its allergenic cross-reactivity with other members of the ole e 1-like protein family of common 
allergenic plants, the nucleotide sequence homology of the acacia ole e 1-like protein was evaluated. 
amplification of cdna strands encoding acacia ole e 1-like protein was performed by polymerase 
chain reaction (PCR) and sequenced. Following expression in escherichia coli using the pet-21b(+) 
vector, the recombinant protein was purified using metal-affinity chromatography. ige-binding com-
petence of purified recombinant ole e 1- like protein (raca f 1) was analysed by immunoassay using  
25 sera collected from acacia pollen-sensitised patients. nucleotide sequencing revealed an open read-
ing frame of 453 bp encoding 150 amino acid residues that belonged to the ole e 1-like protein family, 
and 11 patients (44%) had considerable specific ige levels for the raca f 1. immunodetection and inhi-
bition assays indicated that the purified raca f 1 may be the same as that in the crude extract. aca f 1, 
the second allergen from acacia pollen, was identified as a member of the family of ole e 1-like protein. 
a high degree of homology was found among amino acid sequences of aca f 1 and several allergenic 
members of ole e 1-like protein family.
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Introduction
acacia farnesiana (vachellia farnesiana), a member 
of the Fabaceae family, is a widespread tree throughout 
the tropical and subtropical regions of the United States, 
Asia, Africa, and Australia [1, 2]. Pollens from acacia have 
been reported as a main source of pollinosis in subtropical 
countries such as Iran, Saudi Arabia, and the United Arab 
Emirates, where the frequency of sensitisation ranges from 
25% to 48% [3-8].
Immunochemical analysis of the protein profile of aca-
cia pollen indicated several components ranging from 12 to 
105 kDa. Moreover, the 15, 45, 50, 66, and 85 kDa proteins 
are recognised as dominant IgE-binding components of aca-
cia pollen [1, 9, 10]. A significant IgE cross-reactivity be-
tween the acacia tree and other plants, particularly Prosopis 
juliflora (mesquite) and lolium perenne (rye grass) pollen 
allergens, has also been described [1, 11, 12]. In a recent 
study, Aca f 2, the first allergen from a. farnesiana pollen, 
was identified as belonging to the family of profilins [8]. 
Despite a high prevalence of sensitisation to acacia 
pollen in semiarid countries, there is little information 
about the molecular characterisation of a. farnesiana pol-
len allergens. Here we report Aca f 1, a new allergen from 
acacia pollen, which is a member of the Ole e 1-like pro-
tein family. The first allergenic member of this family was 
isolated from olea europaea pollen as the major allergen 
of olive pollen (Ole e 1) [13]. In previous studies, similar 
allergens were also identified in other plants such as Frax-
inus excelsior (Fra e 1) [14], ligustrum vulgare (Lig v 1) 
[15] syringa vulgaris (Syr v 1) [16], salsola kali (Sal k 5) 
[17], and Chenopodium album (Che a 1) [18]. 
In this study, we expressed and purified Aca f 1 in 
escherichia coli, and subsequently evaluated the immu-
noreactivity of this recombinant allergen. Moreover, the 
nucleotide sequence homology of Aca f 1 was investigated 
with the most common allergenic Ole e 1-like proteins in 
tropical regions. 
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Material and methods
Pollen collection and crude extract preparation
Pollen was collected from the plants during pollination 
season (February-May) from different areas in and around 
Ahvaz city, a tropical region in southwest Iran. Collec-
tion and processing of pollen materials were performed 
with care by trained pollen collectors according to previ-
ous studies [19, 20]. Pollen materials were defatted using 
repeated changes of diethyl ether. Pollen was extracted 
as defined previously [21]. In brief, two grams of pollen 
were mixed with 10 ml of phosphate-buffered saline (PBS) 
0.01 M (pH 7.4) by continuous stirring for 18 hours at 4oC. 
The supernatant was separated by centrifugation at 14,000 
× g for 30 minutes, filtered, and the supernatant collected. 
The extract was then freeze-dried. The protein content of 
the extract was measured using the method of Bradford 
[22]. Finally, the extract was freeze-dried and stored at 
–20°C for later use in the current study.
Study population and skin prick tests (SPTs)
Twenty-five patients with SPT positive for acacia 
pollen and respiratory allergy history participated in this 
study. Five additional subjects who showed negative SPT 
responses and no specific IgE to a. farnesiana pollen ex-
tract were included as negative controls. All patients and 
controls provided informed consent. SPTs were performed 
by an experienced nurse under a physician’s supervision, 
and patients with a positive SPT donated a serum sample. 
Afterwards, patients’ serum samples were immediately 
stored at −20°C before use.
Evaluation of total and specific IgE 
Total serum IgE levels were measured using a com-
mercially available ELISA kit according to the manufac-
turer’s instructions (Euroimmun, Lübeck, Germany). For 
the detection of specific IgE against a. farnesiana pollen 
proteins in allergic patients, an indirect ELISA was devel-
oped. For this purpose, 3 μg/well of a. farnesiana pollen 
extract in 100 μl carbonate buffer (15 mM Na
2
CO
3
 and 
35 mM NaHCO
3
, pH 9.6) was incubated at 4°C overnight 
in a 96-well ELISA microplate (Nunc A/S, Roskilde, Den-
mark). The plates were blocked with 150 μl of PBS-2% 
bovine serum albumin (BSA) solution (1 hour at 37°C) 
and then incubated with 100 μl of patients’ sera for three 
hours at room temperature with shaking. Each well was 
then incubated for two hours at room temperature with 
a 1 : 500 dilution of biotinylated goat anti-human IgE anti-
body (Nordic-MUbio, Susteren, Netherlands) in 1% BSA. 
Following five gentle washes with T-PBS (PBS contain-
ing 0.05% Tween 20) 100 μl of a 1 : 10,000 dilution of 
horseradish peroxidase-conjugated streptavidin (Bio-Rad 
laboratories, Hercules, CA, USA) (diluted in PBS – 1% 
BSA) and incubated for one hour at room temperature. 
After an additional washing step, 100 μl of a tetramethyl-
benzidine (TMB-H
2
O
2
; Sigma-Aldrich, St. Louis, MO) 
substrate solution was used as the HRP-substrate. Fol-
lowing a 20-minute incubation in the dark, the reaction 
was stopped by the addition of 100 μl of 3 M HCl. Then, 
the optical density (OD) in each well was determined at 
450 nm using an ELISA reader. OD three times greater 
than the mean values of three determinations of pooled 
sera from negative controls (i.e. > 0.16 OD units) was con-
sidered to be positive.
Amplification of Aca f 1 gene and sequencing
Following the isolation of total RNA and synthesis of 
cDNA, the coding sequence of Aca f 1 was cloned us-
ing a degenerate forward primer and reverse primer used 
for cDNA amplification, designed according to consensus 
nucleotide sequences for reported allergens from the 
Ole e 1-like protein family, which had a high degree of 
amino acid sequence identity [14, 17, 18, 23-25]. These in-
clude the forward and reversed primers 5′-ACKATKTTY-
CCMAACCTCCA-3′ and 5′-TTAATTAGCTTTAACAT-
CATAAAGATCC-3′, respectively.
The amplified fragment was ligated into a pTZ57R/T 
TA cloning vector using the InsTAcloneTM PCR Cloning 
Kit (Thermo Scientific, Waltham, MA, USA), according 
to the manufacturer’s instructions. escherichia coli TOP10 
cells (Invitrogen, Carlsbad, CA, USA) were transformed 
with the recombinant pTZ57R/T vector using the manu-
facturer’s protocol. Recombinant plasmid was subsequently 
purified from the gel using a Plasmid Extraction Kit (GeNet 
Bio, Chungnam, Korea) and sequenced using the dideoxy 
chain termination method at Bioneer Inc. (Daejeon, Ko-
rea). The DNA sequence of Aca f 1 was submitted to the 
NCBI GenBank database of (http://www.ncbi.nlm.nih.
gov/) under accession number KR870435.
Production and purification of recombinant Aca f 1 
(rAca f 1) allergen
Specific primers for the amplification of Aca f 1 
cDNA were designed using the obtained sequence of Aca 
f 1. These contained overhangs with not I and Xho I re-
striction sites for direct cloning into expression plasmid 
pET-21b(+) (Novagen, Gibbstown, NJ, USA) as follows: 
the sense primer (5′-TCCGCGGCCGCACKATKTTYC-
CMAACCTCCA-3′, not I restriction site is bolded) and the 
antisense primer (5′-CCCTCGAGTTAATTAGCTTTAA-
CATCATAAAGAT-3′, Xho I restriction site is bolded). After 
PCR amplification, the resulting product was digested with 
not i and Xho I restriction enzymes according to the manu-
facturer’s protocol (Thermo Scientific, Waltham, MA, USA). 
After digestion of the PCR product and ligation into the di-
gested pET-21b (+) plasmid with the same enzymes, correct 
constructs were transformed into competent e. coli BL21 
(DE3) cells (Novagen, Gibbstown, NJ, USA). Subsequently, 
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a clone of recombinant plasmid pET-21b(+)/Aca f 1 was in-
oculated into 2 ml of Lysogeny broth (LB) medium contain-
ing 100 μg/ml of ampicillin and incubated at 37°C. Expression 
of rAca f 1 was induced by isopropyl β-D thiogalactopyrano-
side (IPTG) to a concentration of 0.5 mM. Subsequently, the 
cells were isolated by centrifugation (3500 × g, 20 minutes, 
4°C), resuspended in lysis buffer (50 mM Tris–HCl pH 6.8, 
15 mM imidazole, 100 mM NaCl, 10% glycerol, and 0.5% 
Triton X-100) and then disrupted by sonication. Purification 
of rAca f 1 was performed using Ni-NTA affinity chroma-
tography (Invitrogen, Carlsbad, CA, USA) from the soluble 
phase of the lysate, following the manufacturer’s instructions.
Quantification of Specific IgE to rAca f 1  
by ELISA
An indirect ELISA was developed for the determination 
of levels of specific IgE against rAca f 1 using acacia al-
lergic patients’ sera, as previously reported [26]. The wells 
of the ELISA microplate were coated with 100 μl/well of 
purified recombinant rAca f 1 (3 μg/ml).
IgE-binding reactivity of rAca f 1  
by immunoblotting assay
Sodium dodecyl sulphate polyacrylamide gel elec-
trophoresis (SDS-PAGE) of acacia pollen extract was 
performed using 12.5% acrylamide separation gels as de-
scribed previously [8]. The protein bands from the electro-
phoresis of acacia pollen extract or purified rAca f 1 were 
electro-transferred to polyvinylidene difluoride (PVDF) 
membranes (GE Healthcare, UK), and after blocking and 
washing, membranes were incubated with a serum pool or 
individual sera from patients with acacia allergy or with 
control sera (1 : 5 dilutions) for three hours. Biotinylated 
goat anti-human IgE (Nordic-Mubio, Susteren, Netherlands) 
(1 : 1000 v/v in PBS) was added to detect specific IgE, 
and the blotted membrane strips were then incubated with 
1 : 12,000 v/v in TPBS-HRP-linked streptavidin (Sigma- 
Aldrich, St. Louis, Mo, USA). Finally, strips were incubated 
with Super signal West Pico Chemiluminescent Substrate 
Kit (Thermo Scientific, Waltham, MA, USA) for five min-
utes, and proteins were then visualised by chemilumines-
cence using ChemiDoc XRS+ system (Bio-Rad).The mo-
lecular masses of protein bands were estimated using Image 
Lab Analysis Software (Bio-Rad) by comparison with pro-
tein markers of known molecular weights (Amersham Low 
molecular weight Calibration Kit for SDS electrophoresis, 
GE Healthcare, UK). 
Evaluation of cross-reactivity using in vitro 
inhibition assays
ELISA inhibition assay were performed as reported pre-
viously [19, 20]. In this method a pooled serum (1 : 2 v/v) 
from hyper-reactive acacia allergic patients (No. 1, 3, 8, 
and 9) was pre-incubated for overnight at 4°C with either 
1000, 100, 10, 1, 0.1, or 0.01 μg of rAca f 1 as inhibitors or 
with BSA as a negative control before use. The percentage 
inhibition was calculated using the following formula: (OD 
of sample without inhibitor-OD of sample with inhibitor/
OD of sample without inhibitor) × 100.
To study cross-inhibition between natural and recombi-
nant Aca f 1, a mixture of 100 μl of pooled serum (1 : 5 v/v) 
was incubated with natural acacia pollen extract (15 μg/ml, 
as inhibitor), rAca f 1 (8 μg/ml, as inhibitor), or BSA (as nega-
tive control) overnight at 4°C with shaking. Preincubated sera 
were used to assess the reactivity of a PVDF membrane blot-
ted with natural acacia pollen extract and rAca f 1.
Table 1. Clinical characteristics of the patients, skin prick test reactivity, and specific IgE values to recombinant Aca f 1
Aca f 1-reactive 
patients
Age (years)/sex Clinical 
characteristics
Serum total IgE 
(IU/ml)
Acacia pollen extract rAca f 1-specific IgE
Skin prick test1 Specific IgE2
1. 26/M A, R, L 360 10 1.93 1.25
2. 37/F A, R 252 8 1.72 0.78
3. 30/F A, R 178 8 1.86 1.00
4. 20/M A, L 164 6 0.96 0.67
5. 24/M A, R, L 291 9 0.86 0.76
6. 22/F A, R 135 7 1.50 0.93
7. 35/F A, R 158 6 0.83 0.95
8. 34/F A 132 9 1.80 1.10
9. 30/M A, R 164 8 1.32 1.12
10. 31/F A, L 174 6 0.70 0.71
11. 22/F A, R 224 8 1.58 0.94
M – male; F – female; A – allergic rhinitis; L – lung symptoms (breathlessness, tight chest, cough, wheeze); R – rhinoconjunctivitis 
1the mean wheal areas are displayed in mm2. Histamine diphosphate (10 mg/ml) – positive control, glycerine – negative control.  
2determined in specific elisa as od (optical density) at 450 nm
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Results
Patients and SPTs
Twenty-five patients – 11 males and 14 females (mean 
age: 28.56 ±5.93 years; age range 19-40 years) – were in-
cluded in present study. All patients suffered from respira-
tory allergies and seasonal rhinitis during pollination season 
of acacia. The patients were all positive by SPT with aca-
cia pollen extracts (Table 1). A serum pool of five non- 
allergic subjects who showed negative SPT responses and 
no specific IgE against acacia pollen extract were consid-
ered as negative control.
Total and specific IgE levels
The mean total IgE of patients’ sera was determined 
as 256.63 IU/ml. In Aca f 1 reactive patients, the mean of 
total IgE was 202.90 IU/ml (Table 1). Serum from 25 aller-
gic patients were assessed for specific IgE binding to pro-
teins from acacia pollen extract. All of these patients had 
significantly elevated specific IgE levels to the extract of 
acacia pollen (mean: OD
450,
 1.15 ±0.46; range: 0.70-2.3). 
The mean OD
450
 for specific IgE in rAca f 1 reactive pa-
tients was 1.36 ±0.45; range: 0.70-1.93) (Table 1).
Analysis of nucleotide and deduced amino acid 
sequences of Aca f 1
The sequence analysis of Aca f 1 allergen showed an 
open reading frame of 453-bp coding 150 amino acid res-
idues with a predicted molecular mass of 16.525 kDa and 
a calculated isoelectric point (pI) of 4.62. The obtained 
nucleotide sequence was submitted to the NCBI GenBank 
(Accession Number: KR870435).
Fig. 1. Comparison of the acacia farnesiana Ole e 1-like protein (Aca f 1) amino acid sequence with allergenic Ole e 1-like 
protein from other plants: Chenopodium album (Che a 1, G8LGR0.1), Crocus sativus (Cro s 1, XP004143635.1), salsola kali 
(Sal k 5, ADK22842.1), olea europaea (Ole e 1, P19963.2), Fraxinus excelsior (Fra e 1, AAQ83588.1), syringa vulgaris 
(Syr v 1, S43243), and ligustrum vulgare (Lig v 1, O82015.2). The amino acid sequence identity and the similarity of 
Aca f 1 (KR870435) to other members of the Ole e 1-like family are indicated in Table 2. The top line indicates the location 
of secondary structures created by PSIPRED protein sequence analysis (http://bioinf.cs.ucl.ac.uk/psipred/). Cylinder, arrows, 
and black line correspond to α-helices, β-strands, and coil structure, respectively
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To evaluate sequence homology between Aca f 1 and 
the known allergenic Ole e 1-like protein in the protein da-
tabase, the deduced amino acid sequences of these aller-
genic proteins were compared (Fig. 1). A high degree of 
sequence identity (82%) was detected between Aca f 1 and 
Che a 1 and Cro s 1 (allergen from Crocus sativus pollen) 
(Table 2).
SDS-PAGE and IgE-binding components  
of Acacia pollen extract
The SDS-PAGE separation of the pollen extract 
showed several protein bands in the acacia pollen extract 
with molecular weights ranging from approximately 10 to 
85 kDa (Fig. 2). IgE-binding reactivity of the separated 
protein bands from the electrophoresis of the acacia pollen 
extract was assessed by conducting immunoblotting exper-
iments. The results indicated several IgE-reactive bands 
ranging from around 12 to 85 kDa.
Expression and purification of Aca f 1
A pET-21b (+)/Aca f 1 clone was created and con-
firmed by digestion with notI and XhoI restriction en-
zymes. This recombinant plasmid was expressed in e. coli 
strain BL21 (DE3) pLysS as a fusion protein with His
6
-tag 
in the C-terminus.
The rAca f 1 was present in a soluble form in the su-
pernatant, where it was further purified by Ni2+ affinity 
chromatography to yield purified protein. The purified 
rAca f 1 was quantified using Bradford’s protein assay, 
which indicated that nearly 14 mg of recombinant protein 
had been purified from one litre of the bacterial expression 
medium. SDS-PAGE revealed that the apparent molecular 
weight of the fusion protein was about 17.5 kDa (Fig. 3). 
The allergenic Ole e 1-like protein from acacia pollen, as 
a new allergen, was designated Aca f 1 by the WHO/IUIS 
Allergen Nomenclature Subcommittee.
Table 2. Percentage of similarity and identity between Aca f 1 
and selected allergenic Ole e 1-like proteins
Allergens GenBank 
Accession No.
Aca f 1 
% Similarity % Identity
Che a 1 G8LGR0.1 89 82
Cro s 1 AAX93750.1 88 82
Sal k 5 ADK22842.1 90 77
Ole e 1 P19963.2 63 48
Fra e 1 AAQ83588.1 62 48
Syr v 1 S43243 63 46
Lig v 1 O82015.2 62 46
Che a 1 – Chenopodium album; Cro s 1 – Crocus sativus; Sal k 5 – Salsola 
kali; Ole e 1 – Olea europaea; Fra e 1 – Fraxinus excelsior; Syr v 1 – Syringa 
vulgaris; Lig v 1 – Ligustrum vulgare
Fig. 2. SDS-PAGE and immunoblotting of acacia farne-
siana pollen extract. Lane MW: molecular weight marker 
(GE Healthcare, Little Chalfont, UK); lane 1: Coomassie 
Brilliant Blue stained SDS–PAGE of the crude extract of 
acacia pollen (12.5% acrylamide gel); lane 2: Immuno-
blotting of acacia pollen extract. The strip was first blot-
ted with acacia pollen extract and subsequently incubated 
with pooled sera of acacia allergic patients (n = 5) and 
detected for IgE reactive protein bands. Natural Aca f 1 is 
shown by an arrow
kDa MW 1 2
97.0
66.0
45.0
30.0
20.1
14.4
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Analysis of IgE-binding potential of rAca f 1
The levels of specific IgE to the purified rAca f 1 were 
determined using 25 individual patients’ sera. Eleven pa-
tients (44%) had significant specific IgE levels to rAca f 1 
(Table 1). Serum samples from patients allergic to acacia 
pollen were subsequently tested for IgE reactivity to rAca f 1 
in immunoblotting experiments. The results showed that the 
recombinant form of Aca f 1 was reactive with 11 individ-
uals’ sera (Fig. 3). These results were consistent with those 
obtained from specific IgE ELISA (Table 1).
In vitro inhibition assays
ELISA inhibition experiments were performed to in-
vestigate the IgE-binding potential of the purified rAca f 1 
compared to its natural form in acacia pollen crude ex-
tract. ELISA inhibition results revealed a dose-dependent 
inhibition of the IgE directed to rAca f 1 in patients’ sera 
positive to acacia pollen extract. Pre-incubation of pooled 
serum with 1 mg/ml of rAca f 1 and acacia pollen extract 
Fig. 3. SDS-PAGE and immunoblotting of recombinant 
Aca f 1 (rAca f 1). A) Lane MW: Molecular weight marker 
(GE Healthcare, Little Chalfont, UK ); lane 1: Coomassie 
Brilliant Blue stained SDS–PAGE of soluble fraction of 
cell culture (IPTG-induced pET-21b(+) without insert); 
lane 2: rAca f 1 (IPTG-induced pET-21b(+)/Aca f 1) in 
soluble fraction; lane 3: purified rAca f 1 (as an approxi-
mately 18-kDa recombinant protein) with Ni-NTA affinity 
chromatography on 12.5% acrylamide gel. B) IgE immu-
noblot of purified rAca f 1 using allergic patients’ sera. 
lanes 1-11, probed with sera from patients with positive 
for rAca f 1; lane NC – negative control
revealed significant inhibition (92% and 85%, respective-
ly) of IgE binding to rAca f 1 in microplate wells (Fig. 4).
Immunoblot inhibition assays showed that pre-incuba-
tion of serum samples with rAca f 1 nearly completely in-
hibited the IgE binding to a protein band with an apparent 
molecular weight of 17 kDa (Fig. 5, line 3). Altogether, 
in vitro inhibition assays revealed a similar IgE reactivity 
for rAca f 1 and its natural counterpart in acacia pollen 
extract. In addition, results indicated that pre-incubation of 
serum samples with native crude extract of acacia pollen 
inhibited IgE binding to natural Aca f 1 in acacia pollen 
extract and other reactive proteins (Fig. 5, line 2). How-
ever, pre-incubation of the pooled serum with BSA did not 
affect the IgE-reactivity to rAca f 1 (Fig. 5, line 1).
Discussion
In recent years, the pollen of acacia species such as 
a. farnesiana has been recognised as a cause of respiratory 
allergy in various parts of the Southern hemisphere [1, 4, 6, 
7, 27-31]. Up to now, only one allergen (Aca f 2) of acacia 
97.0
66.0
45.0
30.0
20.1
14.4
 1 2 3 4 5 6
 7 8 9 10 11 NC
A     B  kDa MW 1 2 3
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pollen has ever been identified as a member of the profilin 
family [8]. In this study a cDNA encoding another major 
allergen from acacia pollen has been cloned, expressed, 
and identified as a member of the Ole e 1-like protein fam-
ily, and its importance has been analysed with a population 
of patients living Ahvaz city, Southwest Iran, a tropical 
region in which acacia pollen induces nearly 48% of the 
total sensitisation of patients with allergic rhinitis [4]. This 
allergenic member of the Ole e 1-like protein family of 
a. farnesiana was named Aca f 1 in accordance with the 
International Union of Immunological Societies (IUIS) 
Allergen Nomenclature Subcommittee (http://www.aller-
gen.org/). The IgE-reactivity to some allergenic members of 
Ole e 1-like protein family has been demonstrated between 
30% and 77% in allergic patients in different regions where 
it was considered as a major allergen in pollen of the al-
lergenic plants such as o. europaea (Ole e 1), F. excelsior 
(Fra e 1), C. album (Che a 1), s. kali (Sal k 5), and ligus-
trum vulgare (Lig v 1) [15, 17, 18, 23, 24].
The open reading frame contains 453 bases encoding 
a mature Aca f 1 polypeptide of 150 amino acids, with six 
cysteine residues. Encoded within this open reading frame 
is a 16.5 kDa protein that exhibits molecular characteristics 
similar to known members of the plant Ole e 1-like protein 
family (ranging from 16 to 19 kDa) [14, 17, 24]. More-
over, Aca f 1, like Che a 1, Cro s 1, and Sal k 5 has a con-
served sequence for potential n-glycosylation in the same 
position of the polypeptide chain (Asn-Ile/Leu-Thr-Ala), 
which is actually occupied by a glycan in these proteins.
The results of immunoblotting assay on acacia pollen 
extract using pooled sera from patients also revealed an 
IgE-binding protein band with an estimated MW of 17 kDa 
(Fig. 1).
The IgE-binding capacity of the purified rAca f 1 to 
sera from a. farnesiana allergic patients was evaluated us-
ing specific ELISA and immunoblotting assays in order to 
confirm that rAca f 1 was correctly folded and bound to IgE 
as the natural counterpart in acacia extract. The immuno-
blot analysis with individual patients’ sera demonstrated 
diverse IgE reactivity with six proteins of 15, 17, 28, 39, 
45, and 50 kDa as major IgE binding components. The re-
sults of immunoblotting assays for natural Aca f 1 with an 
apparent molecular weight of 17 kDa were consistent with 
those obtained from rAca f 1. A nearly complete inhibi-
tion of IgE-binding to natural Aca f 1 was also obtained 
after pre-incubation of pooled sera with purified rAca f 1. 
Fig. 4. ELISA inhibition with acacia farnesiana pollen ex-
tract and rAca f 1. Inhibition of IgE-binding to rAca f 1 by 
ELISA using acacia pollen extract and rAca f 1. Control 
experiments were performed with BSA
Fig. 5. Immunoblotting inhibition assays. Lane MW: 
molecular weight marker (GE Healthcare, UK); lane 1: 
acacia protein strip incubated with pooled serum without 
inhibitor (negative control); lane 2: acacia protein strip 
incubated with pooled serum containing 85 μg of acacia 
pollen extract as inhibitor (positive control); lane 3: acacia 
protein strip incubated with pooled serum containing 30 μg 
purified rAca f 1, as an inhibitor
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It seems that rAca f 1 is comprised of IgE-epitopes similar 
to those of its natural counterpart.
Cross-reactivity among acacia pollen components 
with other allergenic plants has been described [1, 11, 
12]. The importance of the acacia and the most allergenic 
members of the Fabaceae (Prosopis juliflora) and the am-
aranthaceae (salsola kali, Chenopodium album) families’ 
pollens have been described as main causes of respiratory 
allergy [3-5, 7]. This study was performed to elucidate the 
amino acid sequence homology of Ole e 1-like proteins to 
prevalent allergenic regional plants. The results of amino 
acid sequence identity analyses revealed that Aca f 1 has 
a significant degree of identity with selected members of 
the allergenic Ole e 1-like protein family from the most 
common allergenic regional plants, particularly C. album 
(Che a 1), Crocus sativus (Cro s 1), and s. kali (Sal k 5) 
(82%, 82% and 77%, respectively). Identification of the 
Aca f 1 sequence will allow further studies on the basis 
of in vitro assays to evaluate the molecular basis of cross- 
reactivity between these important allergenic pollens.
In conclusion, Aca f 1, with a detectably specific IgE 
in 44% of acacia allergic patients and the second allergen 
from the a. farnesiana pollen was identified as a member 
of the Ole e 1-like protein family. Furthermore, the results 
indicate that e. coli is a relevant expression system for the 
production of rAca f 1 with immunoreactivity similar to 
that of the allergen’s natural form. Analysis of the amino 
acid sequences of Aca f 1 and several allergenic members 
of the Ole e 1-like protein family from other plants also 
showed a possibility of cross-reactivity among plants be-
longing to unrelated families, which may be predicted by 
the degree of amino acid sequence identity of potential 
conformational epitopes. However, this hypothesis needs 
to be confirmed in further studies where cross-reactivity 
among these allergens are evaluated using in vitro assays.
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